5-(2-(5H-tetrazol-5-yl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-cyclohexyl-1,6-diethyl-1H-pyrazolo[3,4-b]pyridin-4-amine

ID: ALA4745497

PubChem CID: 162648870

Max Phase: Preclinical

Molecular Formula: C23H31N9O

Molecular Weight: 449.56

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCc1nc2c(cnn2CC)c(NC2CCCCC2)c1C1=NOC2(C1)CC(C1N=NN=N1)C2

Standard InChI:  InChI=1S/C23H31N9O/c1-3-17-19(18-12-23(33-29-18)10-14(11-23)21-27-30-31-28-21)20(25-15-8-6-5-7-9-15)16-13-24-32(4-2)22(16)26-17/h13-15,21H,3-12H2,1-2H3,(H,25,26)

Standard InChI Key:  GURINCBMWKPPBD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 38  0  0  0  0  0  0  0  0999 V2000
   12.0960  -11.0691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8794  -11.8650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6753  -12.0817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8920  -11.2858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7673  -10.0828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4838   -9.6694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4810   -8.8388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7656   -8.4297    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0524   -9.6699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0491   -8.8456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2640   -8.5940    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7821   -9.2629    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2695   -9.9278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0059   -7.8103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5556   -7.1949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1939   -8.4236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1909   -7.5985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7672  -10.9079    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0524  -11.3203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3414  -10.9053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6290  -11.3141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6245  -12.1396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3388  -12.5544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0576  -12.1439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1996  -10.0785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2871  -10.8988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5059  -10.3539    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.9528   -9.7417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.0859  -12.7980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7474  -13.5503    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3583  -14.1048    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0746  -13.6952    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.9060  -12.8875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  1  1  0
  9  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8 10  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13  9  1  0
 11 14  1  0
 14 15  1  0
  7 16  1  0
 16 17  1  0
  5 18  1  0
 18 19  1  0
 19 20  1  0
 19 24  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 25 26  1  0
 26  1  1  0
  1 27  1  0
 27 28  1  0
 28 25  2  0
  6 25  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 29  1  0
  3 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4745497

    ---

Associated Targets(Human)

PDE4B Tclin Phosphodiesterase 4B (2748 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE7A Tclin Phosphodiesterase 7A (1104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 449.56Molecular Weight (Monoisotopic): 449.2652AlogP: 5.19#Rotatable Bonds: 6
Polar Surface Area: 113.77Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.85CX LogP: 3.13CX LogD: 3.13
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.65Np Likeness Score: -0.79

References

1. Peng T,Qi B,He J,Ke H,Shi J.  (2020)  Advances in the Development of Phosphodiesterase-4 Inhibitors.,  63  (19): [PMID:32255344] [10.1021/acs.jmedchem.9b02170]

Source